Rapid recovery of platelet count following administration of liposome-encapsulated clodronate in a mouse model of immune thrombocytopenia

British Journal of Haematology

Volumn 116, Issue 2, 2002, Pages 357-366

  Alves Rosa, Fernanda ^a   Stanganelli, Carmen ^b   Cabrera, Juana ^b   Cymberknop, Dora ^b   Rubel, Carolina ^a   Vanzulli, Silvia ^c   Van Rooijen, Nico ^d   Palermo, Marina ^a   Isturiz, Martín A ^a  

^a División Inmunología   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Immune thrombocytopenia; ITP; LIP CLOD; RES blockade

Indexed keywords

ANTIBODY; CLODRONIC ACID; FIBRINOGEN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; BINDING ASSAY; BLEEDING TIME; CONTROLLED STUDY; FEMALE; HEMOSTASIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOCOMPETENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SHEEP ERYTHROCYTE; SPLEEN CELL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

EID: 0036179150     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03281.x     Document Type: Article

References (47)

1. The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets
2. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura (ITP) in a mouse model
3. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation
4. The significance of platelets increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis
5. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice
6. Randomized trial of intravenous immunoglobulin G, anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura
7. Management of chronic immune thrombocytopenic purpura in children and adults
8. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice
9. Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen. II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent
10. Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin
11. Demonstration that thiazole orange-positive platelets in dogs are less than 24 hours old
12. Idiopathic thrombocytopenic purpura. A practice guideline developed by explicit methods for the American Society of Hematology
13. Chronic idiopathic thrombocytopenic purpura
14. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms
15. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura
16. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura
17. The bleeding time as screening test for evaluation of platelet function
18. Evidence that interleukin-6 does not play a role in the stimulation of platelet production after induction of acute thrombocytopenia
19. Recommended method for indium-111 platelet survival studies
20. Autoimmune (idiopathic) thrombocytopenic purpura
21. Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders
22. Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs
23. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): Mechanisms of action
24. Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo
25. Assessment of platelet function
26. Therapy for adults with refractory chronic immune thrombocytopenic purpura
27. Phagocytosis of platelets by Kupffer cells in immune thrombocytopenia
28. A case of diaphragm hernia containing accessory spleen and great omentum detected by Tc-99m phytate scintigraphy
29. (NZW x BXSB) F1 mouse. A new animal model of idiopathic thrombo-cytopenic purpura
30. Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model
31. Contactual lysis of antibody-coated chicken red erythrocytes by purified lymphocytes
32. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis
33. Whatever happened to vinca-loaded platelets?
34. Reticulated platelet counts in the assessment of thrombocytopenic disorder
35. Displacement of platelets from blood to spleen following intravenous injection of liposomes encapsulating dichloromethylene bisphosphonate
36. Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura
37. Good correlation between clinical bleeding tendencies and bleeding pattern from the bleeding time incision
38. The liposome mediated macrophage 'suicide' technique
39. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications
40. Elimination, blocking, and activation of macrophages: Three of a kind?
41. Macrophages in host defence mechanisms
42. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: A micromethod for the detection of platelet activation
43. Macrophages are major source of acetaldehyde in circulating acetaldehyde-albumin complexes formed after exposure of mice to ethanol
44. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens
45. Dual role for macrophages in vivo in pathogenesis and control of murine Salmonella enterica var. Typhimurium infections
46. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: An update